Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2022

Jul 12, 2022

30870_dirs_2022-07-12_082ecbc8-1f47-47a1-b682-640df331aa9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-07-01

Reporting Person: SMITH SANDFORD D (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-07-01 Common Stock A 137 $41.00 Acquired 12170 Direct

Footnotes

F1: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Share are fully vested from the moment of grant. Shares are issued at per share price of $41.00, representing the closing stock price of the Issuer's common stock on July 1, 2022.